COREG CR and lisinopril (FDC)

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Hypertension

Phase 1

Study to Investigate Dose Proportionality of the Fixed Dose Combination of COREG CR and Lisinopril.

CompletedNCT00549510

GlaxoSmithKlineHypertension

Start: 2007-10-31End: 2007-12-31Updated: 2010-10-15

Study to Examine the Effect of Food on the Pharmacokinetics of the Fixed Dose Combination of COREG CR and Lisinopril.

CompletedNCT00557128

GlaxoSmithKlineHypertension

Start: 2007-11-30End: 2007-12-31Updated: 2010-10-15